IDgene Pharmaceuticals Ltd.
This article was originally published in Start Up
Executive Summary
IDgene Pharmaceuticals Ltd. is collecting genetic and clinical data from 2.5 million Israeli Ashkenzi Jews to identify the genetic roots of common diseases and illuminate their underlying biochemical pathways. The company will provide pharmaceutical partners with validated targets and in the future, pursue some drug development on its own.